Home  >  Products  >  COL4A3 (collagen, type IV, alpha 3 (Goodpasture antigen)) Blocking Peptide (the middle region of COL4A3)(100ug)
COL4A3 (collagen, type IV, alpha 3 (Goodpasture antigen)) Blocking Peptide (the middle region of COL4A3)(100ug)

COL4A3 (collagen, type IV, alpha 3 (Goodpasture antigen)) Blocking Peptide (the middle region of COL4A3)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-COL4A3 Antibody (ARP60006_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP60006
Size: 100ug
Weight: 137kDa
Gene: 1277
Format: Lyophilized powder
Target: This gene encodes the pro-alpha1 chains of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIA, Ehlers-Danlos syndrome Classical type, Caffey Disease and idiopathic osteoporosis. Reciprocal translocations between chromosomes 17 and 22, where this gene and the gene for platelet-derived growth factor beta are located, are associated with a particular type of skin tumor called dermatofibrosarcoma protuberans, resulting from unregulated expression of the growth factor. Two transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene.
Alternative names: OI4
See Full Product Listings >